HENNER DENNIS

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
27
Insider Sells Sum
$42.96M

Insider Activity of HENNER DENNIS

The largest sale of all time was on 2004-11-23 and amounted to 868055 shares of Rigel Pharmaceuticals, Inc. for $20.39M.

Biography of HENNER DENNIS

No biography is available at this moment.

2005-01-05SaleRigel Pharmaceuticals, Inc.
RIGL
director
17,253
0.0878%
$23.26$401,378-15.18%
2004-11-23SaleRigel Pharmaceuticals, Inc.
RIGL
director
868,055
4.2507%
$23.49$20.39M-15.62%
2004-09-01SaleRigel Pharmaceuticals, Inc.
RIGL
24,500
0.1383%
$21.13$517,719+1.62%
2004-08-31SaleRigel Pharmaceuticals, Inc.
RIGL
60,527
0.3291%
$20.60$1.25M-0.34%
2004-08-20SaleRigel Pharmaceuticals, Inc.
RIGL
27,499
0.1482%
$21.84$600,619-6.15%
2004-08-19SaleRigel Pharmaceuticals, Inc.
RIGL
5,000
0.0272%
$21.77$108,847-4.87%
2004-08-18SaleRigel Pharmaceuticals, Inc.
RIGL
5,400
0.0294%
$21.80$117,720-4.87%
2004-08-17SaleRigel Pharmaceuticals, Inc.
RIGL
13,599
0.077%
$22.44$305,216-3.85%
2004-08-13SaleRigel Pharmaceuticals, Inc.
RIGL
10,000
0.0589%
$22.30$223,000+0.51%
2004-06-28SaleRigel Pharmaceuticals, Inc.
RIGL
2,877
0.0161%
$15.83$45,545+26.08%
2004-06-25SaleRigel Pharmaceuticals, Inc.
RIGL
54,500
0.3092%
$15.80$861,182+28.38%
2004-06-24SaleRigel Pharmaceuticals, Inc.
RIGL
69,807
0.3808%
$15.54$1.08M+25.51%
2004-06-23SaleRigel Pharmaceuticals, Inc.
RIGL
388
0.0022%
$15.50$6,014+29.57%
2004-06-22SaleRigel Pharmaceuticals, Inc.
RIGL
29,805
0.1637%
$15.51$462,153+26.65%
2004-06-02SaleRigel Pharmaceuticals, Inc.
RIGL
2,030
0.0114%
$18.00$36,540+11.16%
2004-06-01SaleRigel Pharmaceuticals, Inc.
RIGL
10,000
0.0553%
$17.95$179,500+10.16%
2004-05-28SaleRigel Pharmaceuticals, Inc.
RIGL
3,950
0.022%
$18.00$71,100+10.53%
2004-05-27SaleRigel Pharmaceuticals, Inc.
RIGL
20,154
0.111%
$17.85$359,672+10.34%
2004-05-26SaleRigel Pharmaceuticals, Inc.
RIGL
5,861
0.0324%
$17.80$104,326+10.97%
2004-05-24SaleRigel Pharmaceuticals, Inc.
RIGL
3,300
0.0184%
$17.35$57,255+14.66%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.